| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |